nuclear factorkappa b essential modulator nemo deficiency syndrome rare type primary immunodeficiency disease highly variable set symptoms prognoses mainly affects skin immune system potential affect parts body including lungs urinary tract gastrointestinal monogenetic disease caused mutation ikbkg gene ikkγ also known nfκb essential modulator nemo nemo modulator protein ikk inhibitor complex activated phosphorylates inhibitor nfκb transcription factors allowing translocation transcription factors nucleus link ikbkg mutations nemo deficiency identified ikbkg located x chromosome xlinked therefore disease predominantly affects males however females may genetic carriers certain types forms syndrome involving nemorelated pathways passed parent child autosomal dominant manner means child inherit faulty gene one parent develop condition autosomal dominant type nemo deficiency syndrome affect boys nemo deficiency syndrome may present incontinentia pigmenti ectodermal dysplasia depending type genetic mutation present mutation results complete loss gene function point mutation amorphic genetic mutations ikbkg gene result loss gene function typically present incontinetia pigmenti loss nemo function lethal heterozygous females males xxy karyotype mosaicism gene survive exhibit symptoms incontinetia pigmenti skin lesions abnormalities hair teeth nails variety mutations may cause symptoms ip however involve deletion exons ikbkg hypomorphic genetic mutations ikbkg gene resulting partial loss gene function cause onset anhidrotic ectodermal dysplasia immunodeficiency lack nemo results decreased levels nfκb transcription factor translocation gene transcription turn leads low level immunoglobulin production nfκb translocation unable occur without proper nemo function cell signaling response immune mediators lps ineffective thus leading compromised immune response various forms bacterial infections originally nemo deficiency syndrome thought combination ectodermal dysplasia ed lack immune understood complex disease nemo deficiency syndrome may manifest form several different diseases dependent upon mutations ikbkg gene incontinentia pigmenti ectodermal clinical presentation nemo deficiency determined three main symptoms determine whether patient nemo deficiency immunologic screen test immune system response antigen may used although genetic test way certain many individuals respond differently immunological tests aim treatment prevent infections children usually started immunoglobulin treatment immunoglobulin also known igg antibody blood product given replacement people unable make antibodies mainstay treatment patients affected primary antibody deficiency addition immunoglobulin treatment children may need take antibiotics antifungal medicines prevent infections treat promptly occur regular monitoring checkups help catch infections early autoimmune response occurs treated steroid andor biologic medicines damp immune system relieving symptoms severely affected patients nemo deficiency syndrome treated using bone marrow blood stem cell transplant aim replace faulty immune system immune system healthy httpsenwikipediaorgwikinemodeficiencysyndrome